
Although zzso zzso zzso zzso is an effective treatment zzso in the coronary and peripheral zzso diseases, its efficacy for zzso zzso zzso has not been zzso We assessed the long-term outcome of zzso for symptomatic middle cerebral artery zzso zzso 

We performed zzso in 10 patients with symptomatic high-grade zzso zzso on zzso segment of zzso who had either zzso transient zzso attacks zzso resistant to medical therapy or zzso zzso zzso was performed with a zzso zzso zzso diameter and zzso zzso zzso without zzso of a zzso After zzso we evaluated the possible occurrence of zzso which was defined as zzso zzso on follow-up conventional zzso or increased zzso flow zzso on follow-up zzso zzso up to the baseline zzso 

zzso was successfully performed in 9 patients without any serious zzso One patient had zzso zzso zzso zzso was less than 50% in diameter in all the zzso During follow-up period zzso zzso zzso zzso did not recur in 6 of 7 patients who had had intractable zzso Two patients developed strokes, which were not zzso to the index zzso zzso Among the 6 patients who underwent follow-up conventional zzso or serial zzso zzso was noticed in 3 patients zzso 

Although zzso is not zzso zzso for symptomatic zzso zzso is a relatively safe zzso and can be used to prevent zzso zzso or strokes in selected zzso 

